News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Mersen: Number of shares and voting rights as of April 30, 2025
Mersen discloses total number of voting rights and shares in capital as of April 30, 2025, in compliance with French regulations. Mersen is a global expert in electrical power and advanced materials for high-tech industries -
-
COMMUNIQUÉ DE PRESSE
Ministry of Foreign and European Affairs Showcases Decent Cybersecurity at Innovation Day on Cybersecurity
Ministry of Foreign and European Affairs showcases Decent Cybersecurity's post-quantum solutions at Innovation Day on Cybersecurity, highlighting Slovakia's leadership in advanced technologies and public-private partnerships -
COMMUNIQUÉ DE PRESSE
Accelleron focuses on growth in injection systems and invests in Italy
Accelleron's subsidiary OMT invests in Italy to expand production capacities and strengthen technological leadership in fuel injection systems, aiming to double revenue to USD 150 million by 2029. Total investments of USD 80 million planned -
-
-
COMMUNIQUÉ DE PRESSE
Eurobattery Minerals passed the first phase of evaluation in European Funding Call
Eurobattery Minerals AB's funding application to the 'ERMA Booster Call 2025' program passes first evaluation phase, advancing to next stage. Company emphasizes project's importance for Europe's raw materials resilience and competitiveness -
COMMUNIQUÉ RÉGLEMENTÉ
NFL Biosciences annonce les résultats d’une nouvelle étude menée avec le CEA permettant de mieux décrire l’effet de NFL-101, son traitement first in class contre l’addiction au tabac, mettant notamment en évidence son activité prolongée
NFL Biosciences annonce les résultats d’une nouvelle étude menée avec le CEA sur l'effet prolongé de NFL-101 contre l'addiction au tabac. Nouvelles données sur les zones cérébrales ciblées par le traitement -
COMMUNIQUÉ RÉGLEMENTÉ
NFL Biosciences announces results from a new study conducted with the CEA providing further insight into the effects of NFL-101, its first-in-class treatment for tobacco addiction, and highlighting its prolonged activity
NFL Biosciences announces results from a new study with CEA on NFL-101, a treatment for tobacco addiction, highlighting prolonged activity & unique effect, showcased via PET imaging
